Pricing Log in Create free account

Psyence Biomedical Ltd. (PBM) vs Radiopharm Theranostics Limited - Sponsored ADR (RADX)

Psyence Biomedical Ltd. and Radiopharm Theranostics Limited - Sponsored ADR are both Biotechnology companies. Psyence Biomedical Ltd. and Radiopharm Theranostics Limited - Sponsored ADR are of similar size ($17.0M and $16.5M). Across the 6 metrics below, Radiopharm Theranostics Limited - Sponsored ADR leads on 5 and Psyence Biomedical Ltd. on 1.

Valuation

Metric PBM RADX Biotechnology median
P/E 0.19 — 8.50
P/S n/m — 9.71
P/B 0.08 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.82 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield 534.77% — (33.15%)
Free cash flow yield (807.70%) 0.00% (25.50%)

Profitability

Metric PBM RADX Biotechnology median
Gross margin — — 65.16%
Operating margin — — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (23.52%) 0.00% (56.36%)
Return on assets (6.74%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PBM RADX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (138.35%) (1.97%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric PBM RADX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.09 1.16 4.72
Net debt to EBITDA 1.20 0.08 0.96

Dividend

Metric PBM RADX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PBM RADX Biotechnology median
Market cap 16.47m 16.96m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack